AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published February 13, 2008

American Journal of Neuroradiology 2008;29:419.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A0963v1
29/3/419    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henson, J.W.
Right arrow Articles by Harris, G.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henson, J.W.
Right arrow Articles by Harris, G.J.

REVIEW ARTICLE

Brain Tumor Imaging in Clinical Trials

J.W. Henson, S. Ulmer and G.J. Harris

From the Stephen E. and Catherine Pappas Brain Tumor Imaging Research Program (J.W.H., S.U.), Division of Neuroradiology (J.W.H.), 3D Imaging Service (J.W.H., G.J.H.), Department of Radiology (J.W.H., G.J.H.), and Neurology Service (J.W.H.), Massachusetts General Hospital, Boston, Mass; and Harvard Medical School (J.W.H., G.J.H.), Boston, Mass.

Please address correspondence to John W. Henson, MD, Stephen E. and Catherine Pappas Brain Tumor Imaging Research Program, Massachusetts General Hospital, 55 Fruit St, Yawkey Nine East, Boston, MA 02114; e-mail: henson{at}helix.mgh.harvard.edu

SUMMARY: There are substantial challenges in the radiologic evaluation of tumor size during clinical trials, and it is important for neuroradiologists to have a firm understanding of these issues. This review will examine measurement approaches, response criteria, selection of lesions for measurement, technical imaging considerations, interval between tumor measurements and response confirmation, and validity of imaging as a measure of efficacy.